Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
A Multi-Center Study to Evaluate the Safety and Efficacy of a Urine DEK ELISA in Diagnosis of Subjects With Bladder Cancer
Sponsor: Medical Diagnostic Laboratories, LLC
Terminated
Business decision made not to pursue malignant disease diagnostic devices
A observational or N/A phase clinical study on Bladder Cancer and Dysuria, this trial is terminated or withdrawn. The trial is conducted by Medical Diagnostic Laboratories, LLC and has accumulated 12 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Oct 2025 — Present [monthly]
Terminated
Status: Unknown → Terminated
-
Sep 2024 — Oct 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Aug 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical Diagnostic Laboratories, LLC
For direct contact, visit the study record on ClinicalTrials.gov .